Featuring a slide presentation and related discussion from Dr Laura Huppert, including the following topics:
- Overview of approved antibody-drug conjugates (ADCs) for metastatic hormone receptor-positive HER2-negative breast cancer — trastuzumab deruxtecan, sacituzumab govitecan and datopotamab deruxtecan(0:00)
- Approved and investigational ADCs for metastatic triple-negative breast cancer (17:18)
- Sequencing of ADCs for metastatic HER2-negative breast cancer; future research directions (26:10)
Fler avsnitt av Research To Practice | Oncology Videos
Visa alla avsnitt av Research To Practice | Oncology VideosResearch To Practice | Oncology Videos med Dr Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
